Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001323433 | SCV001514346 | uncertain significance | X-linked severe congenital neutropenia; Thrombocytopenia 1; Wiskott-Aldrich syndrome | 2021-08-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001323433 | SCV002797158 | uncertain significance | X-linked severe congenital neutropenia; Thrombocytopenia 1; Wiskott-Aldrich syndrome | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002546103 | SCV003660037 | uncertain significance | Inborn genetic diseases | 2022-11-21 | criteria provided, single submitter | clinical testing | The c.1156C>T (p.P386S) alteration is located in exon 10 (coding exon 10) of the WAS gene. This alteration results from a C to T substitution at nucleotide position 1156, causing the proline (P) at amino acid position 386 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004692503 | SCV005192413 | uncertain significance | not provided | criteria provided, single submitter | not provided |